FDA Approves Tecovirimat, First Drug for Smallpox Treatment

Tecovirimat (TPOXX) provides a treatment option should smallpox ever be used as a bioweapon and is the first product to be awarded a material threat medical countermeasure priority review voucher.
FDA Approvals

https://ift.tt/2ulGbJE